Skip to content

Comparative study of picosecond 730nm laser and nanosecond 755nm laser in the treatment of freckles

Comparative study of picosecond 730nm laser and nanosecond 755nm laser in the treatment of freckles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076573
Enrollment
Unknown
Registered
2023-10-12
Start date
2023-10-15
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

freckle

Interventions

picosecond 730nm laser:Picosecond 730nm laser therapy
nanosecond 755nm laser:Nanosecond 755nm laser therapy

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All 30 patients were clinically diagnosed with freckles

Exclusion criteria

Exclusion criteria: Suffering from autoimmune diseases, tumors, diabetes, cardiovascular diseases, etc; Suffering from skin diseases (such as psoriasis, eczema, skin cancer, etc.), or obvious erythema, trauma, tattoo, etc. in and around the test area; Patients with obvious pigment metabolism disorder, endocrine disorder, adrenal cortex hypofunction, and advanced vitiligo; Female patients who are pregnant, pregnant or lactating; Had taken retinoic acid drugs within 6 months; Photoallergic patients; Patients who had received any optoelectronic treatment or chemical exfoliation of the face within 1 year;

Design outcomes

Primary

MeasureTime frame
Stain score;Incidence of pigmentation;

Secondary

MeasureTime frame
Pain score;Subjective satisfaction;

Countries

China

Contacts

Public ContactGang Yuan

Affiliated Hospital of Zunyi Medical University

611127345@qq.com+86 189 8420 2288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026